Insanabilis Research

Insanabilis Research Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $460M
Latest Deal Amount

Insanabilis Research General Information

Description

Developer of medically innovative therapies designed to treat serious diseases with limited treatment options.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Excellence Health
Primary Office
  • 548 Market Street
  • San Francisco, CA 94104
  • United States
+1 (415) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Insanabilis Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 08-Jul-2017 $460M 00000 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue

Insanabilis Research Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Intercept(Biotechnology) Formerly VC-backed New York, NY 000 00000 000000 - 000 00000
00000000 000000000 Corporation West Conshohocken, PA 00 000.00 000000 - 000 000.00
0000 00000000 Formerly VC-backed Stamford, CT 00 00000 000000&0 00000
000000 00000000000 Venture Capital-Backed Paris, France 00 000.00 00000000000 000.00
0000000 Formerly VC-backed Boston, MA 0000 000000&0

Ready to get started?

Request a free trial